Ketamine for Migraines and Chronic Headaches: An Emerging Option

Short answer: For people whose migraines or chronic daily headaches have resisted the standard arsenal, ketamine is an emerging option worth knowing about. Early studies and clinical experience show meaningful relief for a substantial share of refractory patients, including reduced intensity and frequency, though the research is younger and the evidence quality lower than for ketamine's established uses. Honest framing: promising, not proven. Here is where things stand.

Why researchers looked at ketamine for headaches

Chronic migraine involves central sensitization in the brain's headache circuitry, where repeated attacks progressively sensitize pain pathways until the alarm fires more easily and more often. Those pathways are NMDA-mediated, the same receptors ketamine blocks, which made it a natural candidate for headaches that no longer respond to triptans, preventives, CGRP medications, or Botox. It is the same logic that earned ketamine its place in other centrally sensitized pain conditions.

What the evidence shows so far

The honest picture is encouraging but early. Studies of ketamine infusions for refractory chronic migraine and cluster headache have reported sustained reductions in intensity and attack frequency for many patients, and real-world data on intranasal ketamine found about half of treatment-refractory migraine patients rating it very effective, with over a third reporting improved quality of life. At the same time, reviews describe the overall evidence as low quality and mixed, with a large controlled trial of infusions for chronic daily headache still working through the pipeline. This is a field in motion, and any clinic offering it should say so plainly.

Who might consider it

Ketamine for headaches belongs at the end of the standard road, not the beginning. The candidates who make sense are people with chronic migraine or daily headache who have adequately tried the established treatments, preventives, acute medications, CGRP agents, and remain disabled by attacks, especially when depression or anxiety ride along, since ketamine's established mood benefits can address both burdens at once. A headache specialist should stay central to your care, with ketamine as an adjunct rather than a replacement.

What treatment looks like

Protocols vary more here than in ketamine's established uses, reflecting the younger evidence: typically IV infusions in a monitored setting, sometimes longer sessions or short series, with response assessed honestly before committing to maintenance. Early response tends to show quickly when it comes, which keeps the trial-and-see phase mercifully short. Screening follows the same rules as all ketamine care, including the factors that defer treatment, and insurance coverage for headache infusions is rare, similar to the chronic pain picture.

Our honest position

We would rather under-promise here: the evidence for ketamine in migraines is a tier below its evidence in depression and neuropathic pain, and anyone who tells you otherwise is selling. What is true is that refractory headache patients have few remaining doors, the mechanism is sound, early results are genuinely encouraging, and a carefully screened, honestly monitored trial of treatment is a reasonable option for the right person. That is the standard we hold at Ketamine Uplift under Dr. O'Neill.

This article is for educational purposes only and is not medical advice. Keep your headache specialist involved in any treatment decision.

The bottom line

For refractory migraines and chronic headaches, ketamine is an emerging option: encouraging early studies, a sound mechanism, and real relief for many patients, on an evidence base that is still maturing. It belongs after standard treatments, with honest expectations. If your headaches have outlasted everything else, call us at (310) 280-4440 for a candid conversation.

Frequently asked questions

Does ketamine help migraines? Early studies and clinical experience show reduced intensity and frequency for many refractory patients, though the overall evidence is still young and lower quality than ketamine's established uses. It is promising rather than proven.

Who should consider ketamine for headaches? People with chronic migraine or daily headache that has resisted standard treatments including preventives and CGRP medications, ideally as an adjunct coordinated with their headache specialist.

How is ketamine given for migraines? Typically as monitored IV infusions, sometimes longer sessions or short series, with response assessed before committing to ongoing treatment. Protocols vary because the evidence base is still developing.

Does insurance cover ketamine for migraines? Rarely, as the use is off-label and considered investigational by most insurers. FSA and HSA funds and financing are the usual routes.